Taking people in DenmarkNo phase
Proton Therapy for Mediastinal Lymphoma (PROMLY)
Key facts
- Where
- Copenhagen, DenmarkSee the site
Where in Denmark
- Dept. of oncologyCopenhagen, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Copenhagen University Hospital, Rigshospitalet
- Trial code
- NCT07817641
- Record updated
- 14 September 2026
- Original description
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.Read full original descriptionShow less
The study aims to investigate whether proton therapy is feasible in a national setting and whether proton therapy can reduce the risk of late toxicity (secondary cancers and heart toxicity) compared to foton therapy.
Inclusion: Patients 18 years or older; Histologically proven Hodgkin or non-Hodgkin lymphoma; Disease constrained within the mediastinum +/- neck and/or axilla involvement; Candidates for curative intended treatment; Signed written informed consent.
Exclusion: Prior radiotherapy to the thorax; Inability to attend full course of radiotherapy or follow-up visits in the outpatient clinic; Other current malignancy.